To this end, the terms ‘riboflavin transporter deficiency, type 1 (hRFT1), 2 (hRFT2) and 3 (hRFT3)’ were recommended (Bosch et al., 2012). This evidence concerns the gene SLC52A3 and hyperinsulinemic hypoglycemia, familial, 4.